vialaudit
AOD-9604·US LEGAL STATUS·LAST CHECKED 1 NOV 2026

Is AOD-9604 legal?

Not as a drug. AOD-9604 has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

RESEARCH-LABELLED SALE
Unapproved drug
PHARMACY COMPOUNDING
No · PCAC voted against
PRESCRIPTION
No approved product
WADA 2026
Prohibited (S2.2.3)

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 1 NOV 2026

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: voted no
Not eligible. The PCAC voted unanimously against it on 4 Dec 2024. FDA now lists it under 'nominated but withdrawn'; it is not in any category that permits compounding.
PCAC review history
  • Dec 4, 2024 · voted against · 12 no, 0 yes · SOURCE ↗
FDA Warning Letters
  • Jan 26, 2022 — Innoveix Pharmaceuticals Inc. (cited: aod-9604, sermorelin, ipamorelin) · LETTER ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Standard FDA posture — RUO does not protect sellers when human-use intent is evident.
Personal possession: Not federally scheduled; possession not federally criminalized.

Sport-body status

WADA 2026
prohibited · class S2.2.3 · in and out of competition
Named under S2.2.3 as a growth hormone fragment.
USADA
NCAA

What we couldn’t verify

AOD-9604 US legal status, checked 12 Oct 2026: research sale Unapproved drug, compounding No · PCAC voted against, prescription No approved product, WADA 2026 Prohibited (S2.2.3), 1 FDA warning letters
AOD-9604 federal, compounding and sport status, checked 12 Oct 2026. Describes the law, not legal advice.

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names AOD-9604. The federal position above applies in all 50 states and DC.

What changed at the last check

2 CHANGES
DateFieldWasNowWhy
12 Oct 2026WADA 2026prohibited (S2.2)prohibited (S2.2.3)Named under S2.2.3 as a growth hormone fragment. source ↗
12 Oct 2026OH state noteOhio Board of Pharmacy summary suspension orders named AOD 9604 as an unapproved drug not permitted to be compounded.removedRemoved. The entry described a OH action that does not name AOD-9604; it applied federal-level or class-wide facts by analogy. source ↗

Questions

3 ANSWERS
Is AOD-9604 legal in the US?

Not as a drug. AOD-9604 has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

Can a pharmacy compound AOD-9604?

Not eligible. The PCAC voted unanimously against it on 4 Dec 2024. FDA now lists it under 'nominated but withdrawn'; it is not in any category that permits compounding.

Is AOD-9604 banned in sport?

Yes. It is prohibited at all times under WADA 2026 class S2.2.3. Named under S2.2.3 as a growth hormone fragment.

Sources

7 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. FDA 503A compounding position
  4. PCAC review, 4 Dec 2024
  5. FDA warning letter to Innoveix Pharmaceuticals Inc., 26 Jan 2022
  6. WADA 2026 Prohibited List
  7. Source for: OH state note
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH